The Affordable Insulin Now Act (hr6833-117) would cap insulin cost-sharing at $35 monthly for private insurance and Medicare beneficiaries, directly affecting the Pharmaceuticals & Biotech industry. Rep. Angie Craig (D-MN) introduced this bill. Pharmaceuticals & Biotech comprises 2.3% of Craig's identifiable donor base ($0.47M), ranking 67th among 247 donor industries within her party.

FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated June 13, 2026 · internal signal score 43/100.